Home Newsfeeds Sanofi Has Agreed To Acquire Provention Bio For $25.00/Share In Cash, Representing An Equity Value Of Approximately $2.9B

Sanofi Has Agreed To Acquire Provention Bio For $25.00/Share In Cash, Representing An Equity Value Of Approximately $2.9B

https://www.sanofi.com/en/media-room/press-releases/2023/2023-03-13-06-00-00-2625367

byBenzinga Newsdesk

March 13, 2023

1 minute read

https://www.sanofi.com/en/media-room/press-releases/2023/2023-03-13-06-00-00-2625367

Elon Musk Claps Back At Facebook Co-Founder’s Consumer Fraud Accusations Against Tesla: ‘Should Go To Jail For Impersonating A Smart Person’

By Ananya Gairola

April 26, 9:45 PM

Elon Musk responded to accusations by Facebook co-founder Dustin Moskovitz, who likened Tesla's business practices to Enron's fraud, alleging massive consumer and securities fraud by Tesla.

TSLA

Wolfspeed, Asure Software, Gold Fields And Other Big Stocks Moving Lower In Thursday’s Pre-Market Session

By Lisa Levin

August 17, 6:22 AM

U.S. stock futures traded higher this morning on Thursday. Here are some big stocks recording losses in today’s pre-market trading session. Tremor International Ltd (NASDAQ: TRMR) shares declined 27.2% to $4.56 in pre-market trading.

AEG